Good evening :)
$
₹
Alcon AG

Alcon AG

ALC

NYSE
Asset Logo

Alcon AG

ALC

NYSE
$74.882.17% (-1.66)
$
₹
$74.882.17% (-1.66)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Large Cap

With a market cap of $37.4B the stock is ranked 433

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

58.56
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.62
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$1.32
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.26
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

5.92%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.46%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 27 analysts reports

Buy
21 analysts
Hold
5 analysts
Sell
1 analyst

Price Upside

+6.05%

Earnings Growth

+14.23%

Rev. Growth

+6.56%

See Detailed Forecast

Company Profile

Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
42.94
42.94
1Y Return
7.25%
7.25%
Buy Reco %
82.14
82.14
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
58.29
58.29
1Y Return
12.11%
12.11%
Buy Reco %
76.47
76.47
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.89
38.89
1Y Return
10.7%
10.7%
Buy Reco %
83.33
83.33
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
25.78
25.78
1Y Return
15.97%
15.97%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
36.17
36.17
1Y Return
6.31%
6.31%
Buy Reco %
76.66
76.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 6.05% growth, versus a trailing 3-year CAGR of 1.72%.

2026
Current$77.31Baseline
Analyst Target - 1 year
Target$81.98+6.05%

All values in $

202220232024202520262027$69.07$77.07$85.06Target+6.05%
2026
Current$77.31Baseline
Analyst Target - 1 year
Target$81.98+6.05%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 6.56% growth, versus a trailing 3-year CAGR of 6.06%.

2025
Current$10.40Baseline
Forecast for Dec 2026
High$11.21+7.82%
Average$11.08+6.56%
Low$10.95+5.29%

All values in $ Billion

2021202220232024202520268.298.719.459.9110.40Low+5.29%Average+6.56%High+7.82%
2025
Current$10.40Baseline
Forecast for Dec 2026
High$11.21+7.82%
Average$11.08+6.56%
Low$10.95+5.29%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 14.23% growth, versus a trailing 3-year CAGR of 11.12%.

2025
Current$3.06Baseline
Forecast for Dec 2026
High$3.54+15.69%
Average$3.5+14.23%
Low$3.37+10.13%

All values in $

2021202220232024202520262.152.232.743.053.06Low+10.13%Average+14.23%High+15.69%
2025
Current$3.06Baseline
Forecast for Dec 2026
High$3.54+15.69%
Average$3.5+14.23%
Low$3.37+10.13%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

2.6
0.2
2.7
0.2
2.6
0.1
2.8
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue2.452.492.452.502.472.592.612.712.652.82
Net Income0.240.220.260.280.350.170.230.210.180
Net Profit Margin10.08%8.93%10.71%11.35%14.15%6.77%9.06%7.98%6.98%0%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Alcon AG 58.561.621.26
Abbott Laboratories42.943.701.56
Intuitive Surgical Inc58.299.742.04
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare ALC with any stock or ETF
Compare ALC with any stock or ETF
Comparing from
ALC
ABT
ISRG
Loading...

Frequently asked questions

  1. Alcon AG (ALC) share price today is $74.88 as of November 6, 2026 at 10:12 PM IST. The stock touched a day high of $75.20 and a day low of $74.12.

  2. Alcon AG stock trades on NYSE under the ticker symbol ALC.

  3. Alcon AG's market capitalization is $37.37B as of November 6, 2026 at 10:12 PM IST.

  4. Alcon AG's price-to-earnings (P/E) ratio is 58.56 as of November 6, 2026.

  5. Alcon AG's price-to-book (P/B) ratio is 1.62 as of November 6, 2026.

  6. Yes, Alcon AG pays a dividend, with a current dividend yield of 0.46%.

  7. Yes, You can buy Alcon AG shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Alcon AG shares in three steps: 1. Search Alcon AG on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Alcon AG trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Alcon AG (ALC) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1335 shares at the current price of $74.88.

Loading...